Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BARRX Medical

Request full access

GI Solutions focuses on the ongoing research and treatment of Barrett's esophagus for the treatment of patients diagnosed with the disease

Sunnyvale, United StatesFounded 2003Biotech & Life Sciences

About BARRX Medical

Founded in 2000 and based in Sunnyvale, California, BARRX Medical, Inc. carved a specific niche within the medical device sector by focusing on treatments for gastroenterological diseases. The company was steered by key figures including President and CEO Greg Barrett and Chief Medical Officer David S. Utley, M.D. Their leadership was pivotal in developing and commercializing a novel approach to managing Barrett's esophagus, a precancerous condition resulting from chronic gastroesophageal reflux disease (GERD).

The company's core business revolves around the HALO Radiofrequency Ablation (RFA) System. This platform provides a minimally invasive solution for gastroenterologists and surgeons to remove diseased esophageal tissue endoscopically. The technology is designed to deliver a controlled burst of radiofrequency energy to the targeted lining of the esophagus, ablating the precancerous cells without damaging the underlying healthy tissue. The goal is to allow the esophagus to heal and be replaced by a normal, healthy lining. The HALO system includes a radiofrequency generator and a portfolio of ablation catheters, such as the HALO360 and HALO90, which are designed to treat different sizes and shapes of affected areas within the esophagus.

BARRX Medical's business model centered on selling these specialized devices to hospitals and outpatient surgery centers where endoscopic procedures are performed. The company's value proposition rested on providing a less invasive alternative to surgical intervention for patients with Barrett's esophagus, thereby potentially preventing the progression to esophageal cancer. Following a series of successful funding rounds and the establishment of robust clinical evidence for its technology, BARRX Medical positioned itself as a significant player in its market. This culminated in its acquisition by Covidien, a global healthcare products company, in a deal announced in late 2011 and completed in early 2012 for approximately $325 million. The acquisition integrated BARRX's technology into Covidien's energy-based device portfolio. Subsequently, Covidien itself was acquired by Medtronic in a major transaction that closed in 2015, placing the BARRX RFA technology under the Medtronic umbrella.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
17
Open positions
None listed
Dealroom signal
25.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Oncology, Gastroenterology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Nov 2011 $325M $325M Covidien —
SERIES D✓Equity / VC Jul 2010 $15M $60M Sutter Hill Ventures · Frazier Healthcare Partners · Greenspring Associates · Highland Capital Partners —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

BARRX Medical website traffic

Latest recorded traffic for BARRX Medical is 140 monthly website visits, up 16.7% over the last three months.

Latest monthly visits140 3-month web change+16.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BARRX Medical in the Sunnyvale ecosystem

Live from Dealroom

The BARRX Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later6 investors entered at this stage

Other known investors1 additional known investor

  • Covidien
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BARRX Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BARRX Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.